Salivary Gland Tumors Sasan Dabiri, M.D. - Assistant Professor - - PowerPoint PPT Presentation

salivary gland tumors
SMART_READER_LITE
LIVE PREVIEW

Salivary Gland Tumors Sasan Dabiri, M.D. - Assistant Professor - - PowerPoint PPT Presentation

Salivary Gland Tumors Sasan Dabiri, M.D. - Assistant Professor Department of Otorhinolaryngology Head & Neck surgery Amir Alam hospital Tehran University of Medical Sciences Salivary Gland Tumors Epidemiology Overall prevalence:


slide-1
SLIDE 1

Salivary Gland Tumors

Sasan Dabiri, M.D. - Assistant Professor Department of Otorhinolaryngology – Head & Neck surgery Amir A’lam hospital Tehran University of Medical Sciences

slide-2
SLIDE 2

Epidemiology

  • Overall prevalence:

– 3% of Head & Neck neoplasms – 100 parotid neoplasms – 10 submandibular neoplasms – 10 minor salivary gland neoplasms – 1 sublingual neoplasm

Salivary Gland Tumors

slide-3
SLIDE 3

Epidemiology

  • The most common neoplasms:

– Benign in anywhere:

Pleomorphic Adenoma

– Malignant in parotid:

Mucoepidermoid Carcinoma

– Malignant in others:

Adenoid Cystic Carcinoma

– Post radiation, benign: Warthin’s tumor – Post radiation, malignant: Mucoepidermoid Carcinoma

Salivary Gland Tumors

slide-4
SLIDE 4

Fine Needle Aspiration / Biopsy

  • Goals are:

– Differentiation of neoplastic and non-neoplastic mass – Differentiation of benign and malignant neoplasm

  • High specificity (96-98%)
  • Good sensitivity (79-96%)

Salivary Gland Tumors

slide-5
SLIDE 5

Fine Needle Aspiration / Biopsy

  • Is it Accurate?

– Highest inaccuracy rates in Parotid

  • Diversity in pathology ( 11 benign & 24 malignant )
  • Other than mixed tumor, are uncommon
  • Morphologically complex
  • Some carcinomas have not malignant cellular appearance

Lower accuracy for diagnosing malignant tumor

Salivary Gland Tumors

slide-6
SLIDE 6

Frozen Section

  • Indications :

– Determination of tumor extension – Evaluation of surgical margin – Non-diagnostic FNA – Incompatible FNA according to clinical judgement

Salivary Gland Tumors

slide-7
SLIDE 7

Imaging

Salivary Gland Tumors

slide-8
SLIDE 8

Imaging

Salivary Gland Tumors

slide-9
SLIDE 9

Imaging

Salivary Gland Tumors

slide-10
SLIDE 10

Imaging

Salivary Gland Tumors

slide-11
SLIDE 11

Imaging

Salivary Gland Tumors

slide-12
SLIDE 12

Imaging

Salivary Gland Tumors

slide-13
SLIDE 13

Imaging

  • Differentiation of benign and malignant tumors

is not the primary goal of CT and MRI; but:

– Anatomical localization – Local, Regional (lymph node), and Distant invasion

  • Overall

– Low intensity in T1 & T2  malignant (high probable)

Salivary Gland Tumors

slide-14
SLIDE 14

Imaging

  • Why MRI is better than CT?

– Well visualized on T1 (especially parotid “fatty gland”)

  • Excellent assessment of margins
  • Deep extension & Infiltration

– Best mapping on T1+ Gd + Fat suppression

  • Bone marrow & cortex: hyposignal

 invasion, well visualized

  • Fatty & bony foramina at skull base: hyposignal

 perineural spread: well visualized

  • Meningeal invasion

Salivary Gland Tumors

slide-15
SLIDE 15

Imaging

  • Perineural invasion for parotid tumor

– Facial nerve

  • entire nerve should be assessed all the way

( even if there is no clinical facial paralysis )

– Auriculotemporal nerve

  • through a small fat pad along the

medial aspect of the lateral pterygoid muscle and just inferior to the foramen ovale

Salivary Gland Tumors

slide-16
SLIDE 16

Imaging

  • Perineural invasion for submandibular tumor

– Hypoglossal nerve

  • Tongue movement impairment

– Lingual nerve

  • Tongue tingling

Salivary Gland Tumors

MRI visualizes :

  • enlarged nerve
  • obliterated fat
  • enlarged ganglion
  • atrophy of the masticator muscles
slide-17
SLIDE 17

Imaging

  • Radionuclide Scanning (Tc 99m)

– Warthin’s tumor – Oncocytoma

Salivary Gland Tumors

Helpful for elderly patients with parotid mass

Aldred Scott Warthin 1866 - 1931

slide-18
SLIDE 18

Imaging

  • Ultrasonography

Pros

– Differentiation of glandular from extraglandular mass – Guiding the biopsy (FNA)

Cons

– Operator dependent – Just in superficial masses

Salivary Gland Tumors

slide-19
SLIDE 19

Pleomorphic Adenoma

Salivary Gland Tumors

  • Epithelial and

Mesenchymal components

  • 10% risk of

malignancy after 15 years

slide-20
SLIDE 20

Warthin’s tumor

Salivary Gland Tumors

  • Papillary Cystadenoma Lymphomatosum
  • Only in parotid
  • Male & cigarette smoking
  • No risk of malignancy
  • bilateral
slide-21
SLIDE 21

Mucoepidermoid Carcinoma

Salivary Gland Tumors

  • Contains mucoid

and epidermoid cells

  • Low, intermediate

and high grade classification

slide-22
SLIDE 22

Adenoid Cystic Carcinoma

Salivary Gland Tumors

  • Perineural invasion
  • Grading according

dominant cells:

  • Cribriform
  • Tubular
  • Solid
slide-23
SLIDE 23

Management

  • Surgery

– primary management in all new and recurrent cases Unless :

  • Surgery cannot be done (patient’s condition)
  • Invasion to skull base
  • Invasion to pterygoid plates
  • Encase carotid artery

Salivary Gland Tumors

T4b

slide-24
SLIDE 24

Management

  • Radiation therapy ± Chemotherapy

– Unable to surgery – Adenoid cystic carcinoma – Intermediate or high grade carcinoma – Close or positive margin – Perineural or perivascular invasion – Lymph node metastasis

Salivary Gland Tumors

In cases with complete resection

slide-25
SLIDE 25

Thanks for Your Attention